Group
Genomics
5 themes63 tickers
10D rank#29of 134 groups
Dive into Genomics, where we explore who's at the cutting edge of gene editing, sequencing hardware, and who interprets all that genetic data. These companies are all about unlocking life's code for biotech and creating healthcare breakthroughs.
Genomics '25: Gene Editing & Genetic Meds+19.22%20.0%
Genomics '25: Genomics Tools & Automation+59.09%20.0%
Genomics '25: Molecular Diagnostics & Clinical Genomics+69.34%20.0%
Genomics '25: Sequencing Hardware+14.36%20.0%
Genomics '25: Synthentic Biology & Biofoundries+24.23%20.0%
As of Aug 6, 2026, 4:22 AM ET
Themes in this group
Build 20260806T082229
| Genomics '25: Synthentic Biology & Biofoundries | 12 | $2.11B | $25.37B | +2.85% | +15.16% | -3.33% | +11.61% | +48.69% | +24.23% | +33.14% | -52.22% | +61.60% | +66.88% | +3.33% | +20.67% |
| Genomics '25: Molecular Diagnostics & Clinical Genomics | 18 | $5.35B | $96.26B | -0.67% | +6.18% | -1.64% | +6.37% | +9.00% | +69.34% | +154.17% | +27.35% | +24.42% | +86.64% | -0.56% | +17.66% |
| Genomics '25: Gene Editing & Genetic Meds | 15 | $1.32B | $19.84B | -0.48% | +5.53% | -16.06% | +5.52% | +11.72% | +19.22% | -2.54% | -40.57% | -0.86% | +80.41% | +1.38% | +0.61% |
| Genomics '25: Genomics Tools & Automation | 14 | $33.06B | $462.85B | +2.24% | +3.82% | +4.73% | +1.53% | +39.84% | +59.09% | +26.37% | -23.69% | +27.91% | +67.54% | +1.18% | +7.94% |
| Genomics '25: Sequencing Hardware | 7 | $81.11B | $567.75B | -1.71% | +3.10% | -4.18% | -0.99% | +5.57% | +14.36% | +51.38% | -64.09% | +3.15% | +44.15% | +4.93% | -7.22% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary